Professor, Neurology, University of Washington School of Medicine

Neurology

Dr. Phillip D. Swanson, MD

Phillip D. Swanson is an expert in the field of Neurology. Phillip Swanson is a published physician. He has 46 papers published. The most current publication "Dietary factors in Parkinson's disease: the role of food groups and specific foods." He accepts Medicare payments and is registered with Medicare.gov.

Publications

Formulations of hormone therapy and risk of Parkinson's Disease.
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.
Response to dr liu et al.
Novel mutations in Ataxia telangiectasia and AOA2 associated with prolonged survival.
Nicotine from edible Solanaceae and risk of Parkinson Disease.
An exceptional family with three consecutive generations affected by Wilson Disease.
Environmental tobacco smoke and Parkinson's Disease.
Occupational factors and risk of Parkinson's Disease: A population-based case-control study.
Dietary fats, cholesterol and iron as risk factors for Parkinson''s Disease.
The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's Disease.
Neural transplantation in Huntington Disease: long-term grafts in two patients.
Calcium channel blockers and beta-blockers in relation to Parkinson''s Disease.
5'' and 3'' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson''s Disease risk: a hypothesis-generating study.
Chaos theory and the treatment of refractory status epilepticus: Who benefits from prolonged anesthesia, and is there a better way?
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's Disease.
Diabetes, smoking, and other medical conditions in relation to Parkinson''s Disease risk.
Scanning speech and word history.
Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's Disease.
No associations between Parkinson''s Disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
Pesticides and risk of Parkinson Disease: a population-based case-control study.
DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's Disease cases and unrelated controls.
Parkinson's Disease risks associated with dietary iron, manganese, and other nutrient intakes.
Paraoxonase 1 promoter and coding region polymorphisms in Parkinson''s Disease.
Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson''s Disease.
Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson''s Disease.
Parkinson's Disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.
Age at onset of Parkinson Disease and apolipoprotein E genotypes.
Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson''s Disease.
Genetic polymorphisms of superoxide dismutase in Parkinson's Disease.
Parkinson's Disease, CYP2D6 polymorphism, and age.
Cerebral air embolism after Central venous catheter removal.
Genetic polymorphism of dopamine D2 receptors in Parkinson''s Disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism.
Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson''s Disease.
The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson''s Disease and does not modify the effect of smoking on Parkinson''s ...
Dietary factors in Parkinson's Disease: the role of food groups and specific foods.
A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's Disease.
Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson Disease.
Selegiline and lymphocyte superoxide dismutase activities in Parkinson's Disease.
Diagnosis of inherited metabolic Disorders affecting the nervous system.
Drug treatment of Parkinson''s Disease: is "polypharmacy" best?
Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson''s Disease.
Vaccine-associated paralytic poliomyelitis. Regional case series and review.
Early contributions to the neurochemistry of sodium and potassium transport.
Oral contraceptives and stroke.
Genotype and age at Parkinson Disease diagnosis.

Schools

Johns Hopkins University School of Medicine
Boston City Hospital Harvard
Baltimore City Hospital
Johns Hopkins Hospital
University London

Procedures Preformed

EEG (Electroencephalogram)
EMG (Electromyography)

Conditions Treated

Alzheimer's Disease
Anterior Horn Disease
Ataxia
Autonomic Disorders
View All

Doctors Specialties

Neurology

Accepted Insurances

Education

Johns Hopkins University
Johns Hopkins Bayview Medical Center
Boston University Medical Center

Hospital

UW Medicine/Harborview Medical Center
University of Washington Medical Center

Drug Facts

NPI NUMBER		1467542324
NPPES Provider LastName		SWANSON
NPPES Provider FirstName		PHILLIP
NPPES Provider ZIPCode		981956166
NPPES Provider State		WA
Specialty Description		Neurology
Total Claim Count		693.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1467542324
Last Name Of The Provider	SWANSON
First Name Of The Provider	PHILLIP
View All

Similar Doctors

	Dr. James F. Bartscher, MD This Doctor is OpenDoctor Recommended.
	Dr. Arthur H. Ginsberg, MD
	Dr. John W. Roberts, MD
	Dr. Lawerence C. Murphy, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas D. Bird, MD
	Dr. Suman Jayadev, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard E. Marks, MD
	Dr. Erica A. Byrd, MD
	Dr. Kien-Ninh I. Ly, MD
	Dr. Paul D. Johnson, MD
	Dr. Shu-Ching Hu, MD
	Dr. Alan J. Velander, MD This Doctor is OpenDoctor Recommended.
	Holly Anderson, PA
	Dr. Leonard A. Scheele, MD
	Dr. Melanie S. Walker, MD
	Drury H. Hall, MN This Doctor is OpenDoctor Recommended.